| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-08 |
| mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
4e-07 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
| mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
3e-06 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-06 |
| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
2e-05 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
2e-05 |